Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Exp Neurol. 2010 Aug 6;226(1):68–83. doi: 10.1016/j.expneurol.2010.08.004

Fig. 10.

Fig. 10

Cannabinoid “tetrad” response in TIP39-KO and WT mice. Tests were performed in the order catalepsy (A), locomotion (B), analgesia on hot-plate (C) and body temperature (D) following administration of the cannabinoid agonist CP55,940 (0.3 mg/kg, i.p.). The only test in which CP55,940 treated TIP39-KO mice differed from TIP39-KO mice receiving vehicle was catalepsy (vehicle treated animals displayed no catalepsy; Bonferroni Posttest, ###P<0.001. WT mice treated with CP55,940 differed from WT receiving vehicle in all four tests ***P<0.001.